Current highlights

  1. Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist

    Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist

    Abstract Full Text Full Text PDF (1,9 MB)
  2. Superior Quality of Life and Improved Surgical Margins Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve: A Prospective Single-surgeon Study of 1552 Consecutive Cases eulogo1

    Superior Quality of Life and Improved Surgical Margins Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve: A Prospective Single-surgeon Study of 1552 Consecutive Cases

    Abstract Full Text Full Text PDF (1,1 MB)
  3. Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer eulogo1

    Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer

    Abstract Full Text Full Text PDF (504 KB)
  4. Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT) eulogo1

    Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT)

    Abstract Full Text Full Text PDF (1,7 MB)
  5. Impact of Adjuvant Radiation Therapy on Urinary Continence Recovery After Radical Prostatectomy

    Impact of Adjuvant Radiation Therapy on Urinary Continence Recovery After Radical Prostatectomy

    Abstract Full Text Full Text PDF (336 KB)

Hot off the press

  1. Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam

    Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam

    Abstract Full Text Full Text PDF (612 KB) Patient Summary
    Corrected
  2. SUCCINCT: An Open-label, Single-arm, Non-randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-line Treatment for Patients with Advanced Urothelial Carcinoma

    SUCCINCT: An Open-label, Single-arm, Non-randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-line Treatment for Patients with Advanced Urothelial Carcinoma

    Abstract Full Text Full Text PDF (348 KB) Patient Summary
    Corrected
  3. Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study

    Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study

    Abstract Full Text Full Text PDF (803 KB) Patient Summary
    Corrected
  4. Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: EAU Guidelines

    Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: EAU Guidelines

    Abstract Full Text Full Text PDF (2,0 MB) Patient Summary
    Corrected
  5. Silodosin to Facilitate Passage of Ureteral Stones: A Multi-institutional, Randomized, Double-blinded, Placebo-controlled Trial

    Silodosin to Facilitate Passage of Ureteral Stones: A Multi-institutional, Randomized, Double-blinded, Placebo-controlled Trial

    Abstract Full Text Full Text PDF (493 KB) Patient Summary
    Corrected

Latest news

  1. November Reviewer of the Month - Dr. Christopher Barbieri

    31 Oct 2014

    Chris Barbieri received his undergraduate degree from Dartmouth College, followed by MD/PhD training at Vanderbilt University School of Medicine. He ...

    November Reviewer of the Month - Dr. Christopher Barbieri

  2. New Associate Editor- Dr. Stephen Boorjian

    2 Sep 2014

    European Urology and The European Association of Urology are pleased to welcome Dr. Stephen Boorjian to the Editorial team in the position of ...

    New Associate Editor-  Dr. Stephen Boorjian

  3. Recognizing the 2013 Impact Factor Contributors

    31 Jul 2014

    ​Editor in Chief Prof. James Catto would like to extend his thanks to our Authors, Reviewers, Readers and Editors who have once again helped put ...

    Recognizing the 2013 Impact Factor Contributors

More news